Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States.

Zuluaga-Sanchez, Santiago; Hess, Lisa M; Wolowacz, Sorrel E; D'yachkova, Yulia; Hawe, Emma; Vickers, Adrian D; Kaye, James A; Bertwistle, David

Zuluaga-Sanchez, Santiago; Hess, Lisa M; Wolowacz, Sorrel E; D'yachkova, Yulia; Hawe, Emma; Vickers, Adrian D; Kaye, James A; Bertwistle, David.

Afiliación

Zuluaga-Sanchez S; RTI Health Solutions, 2nd Floor, The Pavilion, Towers Business Park, Wilmslow Road, Didsbury, Manchester M20 2LS, UK.
Hess LM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.
Wolowacz SE; RTI Health Solutions, 2nd Floor, The Pavilion, Towers Business Park, Wilmslow Road, Didsbury, Manchester M20 2LS, UK.
D'yachkova Y; Eli Lilly GmbH, Koelblgasse 8, 1030 Vienna, Austria.
Hawe E; RTI Health Solutions, 2nd Floor, The Pavilion, Towers Business Park, Wilmslow Road, Didsbury, Manchester M20 2LS, UK.
Vickers AD; RTI Health Solutions, 2nd Floor, The Pavilion, Towers Business Park, Wilmslow Road, Didsbury, Manchester M20 2LS, UK.
Kaye JA; RTI Health Solutions, 1440 Main Street, Suite 310, Waltham, MA 02451, USA.
Bertwistle D; Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK.

Sarcoma ; 2018: 6703963, 2018.

Article en En | MEDLINE | ID: mdl-29785170

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Sarcoma Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Egipto

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google